Increased Moxifloxacin Utilization Associated with an Unrestricted Addition to a Drug Reimbursement Formulary: A Population-Based Analysis
OBJECTIVES:To determine whether utilization of moxifloxacin, a broad-spectrum fluoroquinolone antibiotic, has changed since its addition to the British Columbia provincial formulary in 2009 and to determine whether utilization was guideline concordant.
Saved in:
Main Authors: | Alissa Jade Wright, Fawziah Marra, Mei Chong, Catharine Chambers, William R Bowie, David M Patrick |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2014/243014 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exotic animal formulary /
Published: (2018) -
British National Formulary : 53,. March 2007 /
Published: (2006) -
Preventing unrestricted and unmonitored AI experimentation in healthcare through transparency and accountability
by: Donnella S. Comeau, et al.
Published: (2025-01-01) -
Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery
by: Robin K. Kuriakose, et al.
Published: (2022-01-01) -
Winner’s Optimal Reimbursement in Contest
by: Yong Liu, et al.
Published: (2019-01-01)